Compounded GLP-1s on TikTok: what the science actually says

What did @brandiechamberss actually say?

Honestly, not much, at least not in any medically verifiable way. The transcript captures what appears to be a fragment of casual conversation: "If he's saying he ain't fucking around, I'll knock him like, okay, I used to be." That's it. The health claims aren't in the spoken words, they're in the caption, which reads: "This compound medicine saved me."

So the central claim under scrutiny here is the caption assertion that a compounded GLP-1 medication, presumably compounded tirzepatide or semaglutide given the hashtags, produced a life-changing result. The video is also paired with a discount code for Zappy Health, a telehealth platform, which means this functions as a paid or incentivized promotion regardless of how personal the story feels. Viewers seeing 389,000 views on this should know the line between testimony and advertisement is blurry here.

Does the science back this up?

GLP-1 receptor agonists are among the most studied weight-loss drug classes in recent history, and the data is genuinely impressive. But "compound medicine saved me" is doing a lot of work that the science doesn't quite support in that framing.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced mean weight loss of up to 20.9% of body weight over 72 weeks in adults with obesity. STEP 1 (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg weekly produced roughly 14.9% weight loss versus 2.4% with placebo. These are real, meaningful results for a lot of people.

What the science does not show is that compounded versions of these drugs are equivalent to their FDA-approved counterparts. Compounded semaglutide and tirzepatide are not FDA-approved. They are produced under shortage exemptions. The FDA has explicitly warned that compounded GLP-1s may vary in purity, potency, and salt form, which matters clinically.

What did they get wrong (or right)?

The "saved me" framing is the main problem. It is emotionally resonant but medically irresponsible as a marketing claim. GLP-1 receptor agonists do not cure obesity, diabetes, or any other condition. They manage symptoms and physiology while you take them. SURMOUNT-4 (Aronne et al., 2024, JAMA) showed that patients who stopped tirzepatide regained most of their lost weight within a year. That's not a drug that "saves" you, that's a drug that works while you use it.

The promotion of a specific telehealth platform via discount code, without clear disclosure of the commercial relationship, is also worth flagging. Under FTC guidelines, material connections require disclosure. A caption saying "use my code" is not sufficient disclosure by current standards.

To give credit where it's due: GLP-1 medications have genuinely changed outcomes for many patients with obesity and type 2 diabetes. The personal experience of significant benefit is not fabricated, and for many people these drugs are a meaningful clinical intervention. That part of the story is real.

What should you actually know?

If you're considering a compounded GLP-1 from a telehealth platform, here's what actually matters. First, compounded drugs are not FDA-approved and are not required to demonstrate bioequivalence. The FDA has issued multiple safety communications about compounded semaglutide specifically, including concerns about dosing errors with salt-form products.

Second, telehealth platforms vary significantly in the quality of their prescribing oversight. Some conduct thorough intake evaluations. Others do not. The presence of a discount code in a viral TikTok is not a substitute for clinical judgment.

Third, these medications require ongoing medical supervision. Side effects including nausea, vomiting, gastroparesis, and in rare cases pancreatitis are documented in the literature. Anyone using these drugs should have a provider monitoring their response, not just a subscription refill.

Fourth, the weight comes back when you stop. Planning for that, financially and medically, is part of an honest conversation that discount codes don't cover.